Discontinuation and reinitiation patterns of osteoporosis treatment among commercially insured postmenopausal women
Akhila Balasubramanian,1 M Alan Brookhart,2 Vamshidar Goli1 Cathy W Critchlow1 1Amgen Inc, Thousand Oaks, CA, USA; 2University of North Carolina at Chapel Hill, Chapel Hill, NC, USAObjective: Poor adherence to chronic medications is common and compromises medication effectiveness. We sought to descr...
Main Authors: | Balasubramanian A, Brookhart MA, Goli V, Critchlow CW |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-11-01
|
Series: | International Journal of General Medicine |
Online Access: | http://www.dovepress.com/discontinuation-and-reinitiation-patterns-of-osteoporosis-treatment-am-a14901 |
Similar Items
-
Influence on the bone mineral density and bone metabolism marker after the interruption and reinitiation of monthly minodronate therapy in postmenopausal women with osteoporosis
by: Nobukazu Okimoto, et al.
Published: (2018-06-01) -
Compliance and discontinuation of denosumab treatment in postmenopausal Japanese women with primary osteoporosis or rheumatoid arthritis and osteoporosis
by: Takako Suzuki, et al.
Published: (2017-06-01) -
Predictive values of diagnostic codes for identifying serious hypocalcemia and dermatologic adverse events among women with postmenopausal osteoporosis in a commercial health plan database
by: Florence T. Wang, et al.
Published: (2018-04-01) -
Predictors of cinacalcet discontinuation and reinitiation in hemodialysis patients: results from 7 European countries
by: Douglas S. Fuller, et al.
Published: (2019-05-01) -
Reinitiation and Subsequent Discontinuation of Antiplatelet Treatment in Nonpersistent Older Patients with Peripheral Arterial Disease
by: Martin Wawruch, et al.
Published: (2021-09-01)